Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel Disease.

"Conflict of Interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. LT, RG, IR, RP, RF, HL, PM, and MB were employed by GSK at the time of conducting this study. AE, MG, MK, IH, PH, OW, IA, SR, SH, JV, JG, and WJ were employed by Amsterdam University Medical Centers at the time of conducting this study."

"Funding This project is funded by the European Union’s Horizon 2020 research and innovation programme under Grant Agreement No. ITN-2014-EID-641665. PH, OW, IA, SR SH, and WJ are funded by a grant from Dutch Economic Affairs Top Sector Life Sciences & Health (LSH) - Top Consortia for Knowledge and Innovation’s (TKI), grants no. TKI-LSH T2017, and European Crohn’s and Colitis Organization (ECCO) Pioneer Grant, 2018."